Browse > Article
http://dx.doi.org/10.22424/jdsb.2020.38.4.207

Physiological Characteristics and Anti-Obesity Effect of Milk Fermented by Lactobacillus plantarum KI134  

Kim, Seulki (Korea Food Research Institute)
Lim, Sang-Dong (Korea Food Research Institute)
Publication Information
Journal of Dairy Science and Biotechnology / v.38, no.4, 2020 , pp. 207-221 More about this Journal
Abstract
This study aimed to investigate the physiological characteristics and anti-obesity effects of milk fermented by L. plantarum KI134. The lipase, α-amylase, and α-glucosidase inhibitory activities of milk fermented by L. plantarum KI134 was 94.57±1.25%, 9.44±2.85%, and 2.74±1.24% (10 fold dilution), respectively. L. plantarum KI134 showed higher sensitivity to clindamycin and erythromycin in comparison to sixteen different antibiotics. It demonstrated the highest resistance toward ampicillin and vancomycin. The strain showed higher β-galactosidase, leucine arylamidase, valine arylamidase, acid phosphatase, β-glucosidase, and N-acetyl-β-glucosaminidase activities compared to other enzymes. It also did not produce carcinogenic enzymes, such as β-glucuronidase. The survival rate of L. plantarum KI134 in 0.3% bile was 96.90%. Moreover, the strain showed a 91.45% survival rate at a pH of 2.0. L. plantarum KI134 has resistance to Escherichia coli, Salmonella Typhimurium, Listeria monocytogenes, and Staphylococcus aureus at the rates of 70.00%, 68.18%, 59.05%, and 40.63%, respectively. L. plantarum KI134 (23.01%) showed higher adhesion ability than the positive control (16.32%) L. rhamnosus GG. These results demonstrated that milk fermented by L. plantarum KI134 demonstrated an anti-obesity effect under in vitro conditions, with confirmed potential as a probiotic.
Keywords
Lactobacillus plantarum; physiological characteristics; anti-obesity; fermented milk products;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee KE, et al. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta. 2006;1761:736-744.   DOI
2 Miyoshi M, Ogawa A, Higurashi S, Kadooka Y. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr. 2014;53:599-606.   DOI
3 Sato M, Uzu K, Yoshida T, Hamad EM, Kawakami H, Matsuyama H, et al. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr. 2008;99:1013-1017.   DOI
4 Kang JH, Yun SI, Park HO. Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats. J Microbiol. 2010;48:712-714.   DOI
5 Hong SD, Chung EC. Kim CH. Anti-obesity effect of fermented whey beverage using lactic acid bacteria in diet-induced obese rats. Korean J Food Sci An. 2015;35:653-659.   DOI
6 Park S Y, Seong K S, Lim S D. Anti-obesity effect of yogurt fermented by Lactobacillus plantarum Q180 in diet-induced obese rats. Korean J Food Sci An. 2016;36:77-83.   DOI
7 Lim SD, Kim KS. Do JR. Physiological characteristics and production of vitamin K2 by Lactobacillus fermentum LC272 isolated from raw milk. Korean J Food Sci Anim Resour. 2011;31:513-520.   DOI
8 Lee YP, Chung GH, Rhee JS. Purification and characterization of Pseudomonas fluorescens SIK W1 lipase expressed in Escherichia coli. Biochem Biophys Acta. 1993;1169:156-164.   DOI
9 Xiao Z, Storms R, Tsang A. A quantitative starch-iodine method for measuring alpha-amylase and glucoamylase activities. Anal Biochem. 2006;351:146-148.   DOI
10 Si MM, Lou JS, Zhou CX, Shen JN, Wu HH, Yang B, et al. Insulin releasing and alpha-glucosidase inhibitory activity of ethyl acetate fraction of Acorus calamus in vitro and in vivo. J Ethnopharmacol. 2010;128:154-159.   DOI
11 Hemati N, Ross SE, Erickson RL, Groblewski GE, MacDougald OA. Signaling pathways through which insulin regulates CCAAT/enhancer binding protein-α (C/EBP-α) phosphorylation and gene expression in 3T3-L1 adipocytes: correlation with CLUT4 gene expression. J Biol Chem. 1997;272:25913-25919.   DOI
12 Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochem. 1992;97:493-497.   DOI
13 Hammes WP, Weiss N, Holzapfel W. The genera Lactobacilli and Carnobacterium. In: Martin D, Stanley F, Eugene R, Karl-Heinz S, Erko S, editors. The prokaryotes. 2nd ed. Vol. 4. New York, NY: Sprnger-Verlag; 1992. p. 1563-1578.
14 Kim SJ, Cho SY, Kim SH, Song OJ, Shin IS, Cha DS, et al. Effect of microencapsulation on viability and other characteristics in Lactobacillus acidophilus ATCC 43121. LWT-Food Sci Technol. 2008;41:493-500.   DOI
15 Gilliland SE. Walker DK. Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans. J Dairy Sci. 1990;73:905-911.   DOI
16 Clark PA, Cotton LN, Martin JH. Selection of bifidobacteria for use as dietary adjuncts in cultured dairy foods: II-tolerance to simulated pH of human stomachs. Cult Dairy Prod J. 1993;28:11-14.
17 Gilliand SE, Speck ML. Deconjugation of bile acids by intestinal lactobacilli. Appl Environ Micobiol. 1977;33:15-18.   DOI
18 Gueimonde M, Sanchez B, de los Reyes-Gavilan CG, Margolles A. Antibiotic resistance in probiotic bacteria. Front Microbiol. 2013;4:202.   DOI
19 EFSA. Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J. 2012;10:2740.
20 Colombo M, Castilho NPA, Todorov SD, Nero LA. Beneficial properties of lactic acid bacteria naturally present in dairy production. BMC Microbiology. 2018;18:219.   DOI
21 Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol. 2000;84:197-215.   DOI
22 Hirayama K, Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000;2:681-686.   DOI
23 Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek. 2002;82:279-289.   DOI
24 Hamon E, Horvatovich P, Marchioni E, Aoude-Werner D, Ennahar S. Investigation of potential markers of acid resistance in Lactobacillus plantarum by comparative proteomics. J Appl Microbiol. 2013;116:134-144.   DOI
25 Gilliland SE, Staley TE, Bush LJ. Importance of bile tolerance of Lactobacillus acidophilus used as a dietary adjunct. J Dairy Sci. 1984;67:3045-3051.   DOI
26 Araya M, Morelli L, Reid G, Sanders ME, Stanton C. Guidelines for the evaluation of probiotics in food: report of a joint FAO/WHO working group on drafting the guidelines for the evaluation of probiotics in food. London, UK: Food and Agriculture Organization of the United Nations; 2002.
27 Shulkesa A, Baldwina GS, Giraud AS. Regulation of gastric acid secretion. In: Johnson LR, Barret KE, Gishan FK, Merchant JL, Said AM, Wood JD, editors. Physiology of the gastrointestinal tract. 4th ed. Burlington, MA: Academic Press; 2006. p. 1223-1258.
28 Jacobsen CN, Nielsen VR, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol. 1999;65:4949-4956.   DOI
29 Larsen AG, Vogensen FK, Josephsen J. Antimicrobial activity of lactic acid bacteria isolated from sour doughs: purification and characterization of bavaricin A, a bacteriocin produced by Lactobacillus bavaricus MI401. J Appl Bacteriol. 1993;75:113-122.   DOI
30 Daeschel MA. Antimicrobial substances from lactic acid bacteria for use as food preservatives. J Food Technol. 1989;43:164-167.
31 Havinaar R, Brink BT, Veid JHJI. Selection of strains for probiotic use. In: Fuller R, editor. Probiotics. Dordrecht: Springer-Science Business Media; 1992. p. 209-224.
32 Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2010;316:104-108.   DOI
33 Juge N. Microbial adhesins to gastrointestinal mucus. Trends Microbiol. 2012;20:30-39.   DOI
34 Apostolou E, Kirjavainen PV, Saxelin M, Rautelin H, Valtonen V, Salminen SJ, et al. Good adhesion properties of probiotics: a potential risk for bacteremia? FEMS Immunol Med Microbiol. 2001;31:35-39.   DOI
35 Korea Disease Control and Prevention Agency. Korea Health Statics 2018: Korea Naional health and Nutrition Examination Survey (KNAHANES VII-3). Cheongju: Korea Disease Control and Prevention Agency.
36 Sharma AM, Padwal R. Obesity is a sign-over-eating is a symptom: an etiological framework for the assessment and management of obesity. Obes Rev. 2009;11:362-370.   DOI
37 Kopelman PG. Obesity as a medical problem. Nature 2000;404:635-643.   DOI
38 Nguyen MD. EI-Serag BH. The epidemiology of obesity. Gastroenterol Clin North Am. 2010;39:1-7.   DOI
39 Cope MB. Allison DB. Critical review of the World Health Organization's (WHO) 2007 report on 'evidence of the long-term effects of breastfeeding: systematic reviews and meta-analysis' with respect to obesity. Obes Rev. 2008;9:594-605.   DOI
40 Finkelstein EA, Trogdon JG, Brown DS, Allaire BT, Dellea P, Kamal BS. The lifetime medical cost burden of overweight and obesity: implications for obesity prevention. Obesity. 2008;16:1843-1848.   DOI
41 Cawley J. Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31:219-230.   DOI
42 Kang Y, Cai Y. The development of probiotics therapy to obesity: a therapy that has gained considerable momentum. Hormones. 2018;17:141-151.   DOI